Development of rapid detection methods on cancer-related components in blood and body fluid samples from cancer patients

Development of rapid detection methods on cancer-related components in blood and body fluid samples from cancer patients - Development of rapid detection methods on cancer-related components in blood and body fluid samples from cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020248

Enrollment

500

Registered

2015-12-17

Start date

2015-12-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer (positive control) and benign diseases (negative control)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients with histologically proven cancer and benign disease patients without cancer who are treated in Showa University Koto Toyosu Hospital and Ryukyu University Hospital since 2015. (2) Clinical solitary tumor (cancer patients) (3) No prior treatment (4) Age 20-80 years (5) Eastern Cooperative Oncology Group performance status 0 or 1 (6) Sufficient organ function (7) Written informed consent

Exclusion criteria

Exclusion criteria: (1) Synchronous or metachronous malignancy (2) Pregnant or breastfeeding women

Design outcomes

Primary

Measure	Time frame
Quantitative detection of cancer-related components in blood and body fluid samples from patients with cancer and benign disease.	—

Countries

Japan

Contacts

Public ContactHiroaki Ito, MD, PhD

Showa University Koto-Toyosu Hospital Digestive Disease Center

h.ito@med.showa-u.ac.jp03-6204-6000

Outcome results